Dr. Kenneth C. Andronico, D.O. Ophthalmology Medicare: Medicare Enrolled Practice Location: 28945 State Road 54, Suite 101, Wesley Chapel, FL 33543 Phone: 813-907-0950 Fax: 813-907-7949 |
Dr. Gretta Fridman, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 27348 Cashford Cir, Wesley Chapel, FL 33544 Phone: 813-994-7000 |
Dana Schneider, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 27356 Cashford Cir, Wesley Chapel, FL 33544 Phone: 813-994-7000 |
Ahmad B Tarabishy, MD Ophthalmology - Retina Specialist Medicare: Accepting Medicare Assignments Practice Location: 2400 Cypress Glen Dr, Wesley Chapel, FL 33544 Phone: 813-973-3333 Fax: 813-973-3888 |
Alexander Julien Schneider, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2400 Cypress Glen Dr, Wesley Chapel, FL 33544 Phone: 813-973-3333 Fax: 813-973-3888 |
Dr. Alfred Alfonzo White Jr., M.D. Ophthalmology - Retina Specialist Medicare: Accepting Medicare Assignments Practice Location: 26846 Ridgebrook Dr, Wesley Chapel, FL 33544 Phone: 813-803-7779 Fax: 813-877-4578 |
Dr. Evan Norman Dunn, M.D Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2400 Cypress Glen Dr, Wesley Chapel, FL 33544 Phone: 813-973-3333 Fax: 813-973-3888 |
News Archive
According to a new study published in The Oncologist, patients with advanced cancer who are diagnosed with delirium when turning up in emergency departments are more likely to be admitted to hospital and more likely to die earlier than patients without delirium.
Efforts to prevent new HIV transmissions in the United States must be accompanied by advances in addressing HIV-associated comorbidities to improve the health of people already living with HIV, National Institutes of Health experts assert in the third of a series of JAMA commentaries.
Salix Pharmaceuticals, Ltd. today announced that as of September 30, 2009 Lupin Ltd. granted Salix the exclusive right in the United States to its bioadhesive drug delivery technology for use with rifaximin. Salix and Lupin have entered into a development, commercialization and license agreement under which the two companies will collaborate in the development and commercialization of a product incorporating rifaximin and utilizing Lupin's proprietary technology.
Social learning matters in arresting climate change, just as much as geophysical factors like plant respiration or solar reflectivity of the earth's surface, says a surprising new study. In a pioneering model of socio-climate interaction, researchers linked social dynamics to predicted climate changes themselves, to come up with better ways of preventing climate change mitigation.
› Verified 3 days ago